Clinical Efficacy
Encircle has been developed and tested to deliver the required levels of compression and physiological benefit within the final product design configuration. Preliminary ‘product efficacy’ testing (phase one Doppler ultrasound clinical trials) undertaken independently by the Medical Research Institute of New Zealand has shown Encircle to reduce vein diameter and increase blood velocity, the two key metrics which determine the clinical effectiveness of any therapy used to prevent the buildup of hydrostatic pressure in the venous system.
Professor Richard Beasley, CEO of the Medical Research Institute of New Zealand and an internationally recognized specialist in the field of Deep Vein Thrombosis said “the overall results from the pooled data are very promising. Being able to demonstrate an emerging pattern from pooling a small group of people is a good outcome. There was a clear reduction in vein diameter with the lightest Encircle garment.”
The Encircle Compression Therapy is classified as a Class I medical device which has the lowest compliance threshold for any medical device internationally.
Effects of Encircle